The Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the oncology partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides a detailed understanding and analysis of how and why companies enter oncology partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors oncology technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Request a Sample for or Inquire before buying the report@
ONCOLOGY PARTNERING TERMS AND AGREEMENTS
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.
This report contains over 2,700 links to online copies of actual oncology deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.
Oncology Partnering Terms and Agreements includes:
· Trends in oncology dealmaking in the biopharma industry since 2007
· Analysis of oncology deal structure
· Access to headline, upfront, milestone and royalty data
· Case studies of real-life oncology deals
· Access to over 2,700 oncology contract documents
· The leading oncology deals by value since 2007
· Most active oncology dealmakers since 2007
· The leading oncology partnering resources
Major points covered in Table of Contents of this report include:
Executive Summary
Executive Summary
Introduction
Trends in oncology dealmaking
Leading oncology deals
Leading oncology deals
Bigpharma oncology deals
Dealmaking directory
Partnering resource center
See More Healthcare Market Research Reports
Report Details :
Published: February 2012
No. of Pages:
Price: Single User License - US $ 2995
